{
    "nctId": "NCT05424666",
    "briefTitle": "The Role of Lipofilling After Oncoplastic Breast Surgeries : Evaluation of Outcomes and Patient Satisfaction",
    "officialTitle": "The Role of Lipofilling After Oncoplastic Breast Surgeries : Evaluation of Outcomes and Patient Satisfaction",
    "overallStatus": "UNKNOWN",
    "conditions": "Cancer, Breast",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 20,
    "primaryOutcomeMeasure": "Cosmetic apperance",
    "eligibilityCriteria": "Inclusion Criteria:\n\nFemale gender.\n\nAge of 18 years and older.\n\nHistory or in candidate for a mastectomy in the near future.\n\nPatients undergoing prophylactic mastectomy.\n\nPatients' choice to undergo a breast reconstruction.\n\nWanting to participate in this study.\n\nPatient is able to wear the BRAVA (BRA like VAcuum-based external tissue expander) device.\n\nExclusion Criteria:\n\nActive smoker or a history of smoking 4 weeks prior to surgery.\n\nCurrent substance abuse.\n\nHistory of lidocaine allergy.\n\nFour weeks or less after chemotherapy.\n\nHistory of radiation therapy in the breast region.\n\nOncological treatment includes radiotherapy after mastectomy.\n\nKidney disease.\n\nSteroid dependent (daily or weekly).\n\nImmune-suppressed or immune-compromised disease.\n\nUncontrolled diabetes.\n\nbody mass index of \\>30.\n\nLarge breast size (ie, larger than cup C), unless the patient prefers reduction of the contralateral side towards cup C.\n\nExtracapsular silicone leaking from the encapsulated implant from a previous breast reconstruction.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}